Should I apply? Diagnostics Accelerator Programme

Please join us to find out more about how participating in the Diagnostics Accelerator programme can support in how you approach and position your technology to a healthcare system. We will also cover programme design, application process and eligibility criteria in this session.

Agenda

• 12:00 - 12:10 Introductions and programme overview
• 12:10 - 12:30 Panel discussion from London In Vitro Diagnostics team
• 12:30-1:00 Audience Q&A

Diagnostics Accelerator Programme

One of the most substantial challenges in the development of a novel intervention is adoption by the health system and patients. The most de-risked path to a successful deployment is to validate all of your clinical, financial and social claims with appropriate evidence from a respected body. This way, when you approach the health system, they are comfortable in the knowledge that your product achieves what it is designed to do.

About MedTech SuperConnector

MedTech SuperConnector, funded by Research England, is an Imperial College London led collaboration between eight diverse academic institutions. Through accelerator programmes it aims to fast-track the development of innovative early stage medical technologies, from devices, diagnostics to digital health solutions. MTSC provides programme participants with the funding, training and access to industry partners to support the translation of their medical devices into the real world.

About London-IVD

London In Vitro Diagnostics Co-operative is a partnership between Imperial College London and Imperial College Healthcare NHS Trust. We are one of four NIHR centres in England that generate evidence to support diagnostic test development. We achieve this by developing research methods to expedite evidence generation – and by collaborating with various stakeholders to support this process. We work with clinicians to identify unmet needs for diagnostics – and we work with diagnostic test developers to explore the utility of specific tests within UK NHS settings. By facilitating the adoption of new, improved tests into clinical practice we hope to improve the quality of patient care within the NHS.